Neuropoint GmbH /ID# 226313

Ulm, Baden-Wurttemberg 89073

0 studies enrolling now · 1 studies all time

What they study most

Chronic Migraine, Episodic Migraine

Studies at this site

• A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine — Completed